Dr. Zhang Bo-li is an academician and a China- renowned specialist and academic leader in Chinese internal medicine/ a national key discipline (recognized as important and receiving support by the Chinese government). He is currently the President of the Tianjin University of Traditional Chinese Medicine and the China Academy of Chinese Medical Sciences. He is also the Deputy Chief Engineer of tiie National Major Scientific and Technological Special Project for "SignificantNew Drugs Development'^ Committee of the State Council, Vice Committee Director of the Pharmacopoeia Committee, Director of the National Chinese Medidne Teaching Advisory Board of the Ministry of Education and Director of the Educational Instruction Coirunittee of the World Federation of Chinese Medidne Societies. Moreover, he holds concurrent posts such as Honorary President of the China Assodation of Integrative Medidne, Vice President of the China Association of Traditional Chinese Medicine and Vice President of the World Federation of Chinese Medidne Societies.

For decades, Dr. Zhang has been devoted to the prevention and treatment of cardiovascxilar and cerebrovascular diseases by integrating traditional Chinese medicine with western medicine/ and to the modernization of Chinese medicine (CM). He carried out studies on vascular dementia (VD) and formulated the classification criteria for VD patterns and a treatment scheme based on three phases, i.ev stable, fluctuating and aggravated phases. He specified die patterns and manifestations of stroke as well as the dynamic progression of its premonitory symptoms, and developed a comprehensive therapeutic schedule. He created the pharmacological method of cerebrospinal fluid (CSF) and demonstrated the protective effect of Chinese medidnaJs on nerve cells and the relevant mechanisms. He completed the first large- scale evidence-based study on the secondary prevention of coronary heart disease with Chinese medidnals, and developed a series of methods for evidence-based evaluation on CM. He served as Qiief Scientist of the National Program on Key Basic Research Project of China (973 Program) for three consecutive terms and developed the theory of effect-based compatibility as well as the critical technology for tfie research and development of modem Chinese medidnals through component-based compatibility. He expanded the research field of tile secondary development of Chinese patent medicine which introduced a large group of mass market medicines, and initiated the intelligent manufacturing of Chinese medidnals which promoted the technological upgrading of CM industry.

Dr. Zhang has won 7 national awards (including the first prize for national progress in science and technology) and 10 first-prize provincial and ministerial awards for progress in science and technology. He has published more than 350 papers and over 30 monographs or textbooks. He has mentored and cultivated more than 200 postgraduates.

Dr. Zhang is widely recognized for his prominent contributions in advancing CM_ Since 1991, he has been granted a special government allowance by the State Council. He has been conferred with many honorary titles and awards； including National Advanced Worker (2005), Outstanding Scientific and Technological Worker (2001) and National Young and Middle-aged Expert with Outstanding Contribution (1991) as well as the Ho Leung Ho Lee Prize (2006), Wu Jie-ping Medical Research Award (2015) and International Award for Outstanding Contribution to Chinese Medidne (2010). l6Mj/3+FeoJ5w2UYXKgLbREqR8yPXU+xetVhMH8mZ4CTlR98ls5WGyeRPavzoDq5